Stemline Therapeutics
Biotechnology, 750 Lexington Ave Fl 11, New York, 10022, United States, 51-200 Employees
Phone Number: 16*********
Who is STEMLINE THERAPEUTICS
Stemline is a commercial-stage biopharmaceutical company committed to applying our scientific leadership and commercial expertise to transform the lives of patients with cancer. ELZONRIS ...
Read More
-
Headquarters: 750 Lexington Ave Fl 11, New York, New York, 10022, United States
-
Employees: 51-200
-
Revenue: $10 Million to $25 Million
-
CEO:
Phraew Sakon
Email
Phone
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from STEMLINE THERAPEUTICS
Stemline Therapeutics Org Chart and Mapping
Jessica Gache
Executive Assistant to SVP, Global Regulatory Affairs, Drug Safety, Pharmacovigilance & R&D QA
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Stemline Therapeutics
Answer: Stemline Therapeutics's headquarters are located at 750 Lexington Ave Fl 11, New York, 10022, United States
Answer: Stemline Therapeutics's phone number is 16*********
Answer: Stemline Therapeutics's official website is https://stemline.com
Answer: Stemline Therapeutics's revenue is $10 Million to $25 Million
Answer: Stemline Therapeutics's SIC: 2834
Answer: Stemline Therapeutics's NAICS: 325412
Answer: Stemline Therapeutics has 51-200 employees
Answer: Stemline Therapeutics is in Biotechnology
Answer: Stemline Therapeutics contact info: Phone number: 16********* Website: https://stemline.com
Answer: Stemline is a commercial-stage biopharmaceutical company committed to applying our scientific leadership and commercial expertise to transform the lives of patients with cancer. ELZONRIS a targeted therapy directed to CD123, is FDA-approved and commercially available in the U.S. for the treatment of adult and pediatric patients, two years and older, with BPDCN. In Europe, a marketing authorization application (MAA) is under review by the European Medicines Agency (EMA). Inspired by the goal to improve outcomes for patients with unmet medical needs, Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer. Currently our clinical-stage product candidates in include ELZONRIS, SL-701 and SL801.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month